Retour
91
Fourchette du Jour
26,49 €
27,31 €
Fourchette 52 Semaines
12,91 €
42,13 €
Volume
833 782
Moyenne 50J / 200J
29,58 €
/
25,90 €
Clôture Précédente
27,75 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (627 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -49,2 | 0,4 |
| P/B | 21,5 | 2,9 |
| ROE % | -57,8 | 3,9 |
| Net Margin % | -10,2 | 3,8 |
| Rev Growth 5Y % | 38,9 | 10,0 |
| D/E | 2,9 | 0,2 |
Objectif de Cours des Analystes
Hold
49,00 €
+82.9%
P/E Prévisionnel
73,6
BPA Prévisionnel
0,38 €
Croissance BPA (est.)
+0,0%
CA Est.
700 M
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
5,07 €
3,97 € – 6,32 €
|
1,5 B | 2 |
| FY2029 |
4,07 €
3,19 € – 5,08 €
|
1,3 B | 4 |
| FY2028 |
3,41 €
2,02 € – 5,75 €
|
1,1 B | 6 |
Points Clés
Revenue grew 38,90% annually over 5 years — strong growth
Debt/Equity of 2,86 — high leverage
Generating 37,78M in free cash flow
PEG of 0,79 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 71,55%
Capital efficient — spends only 0,00% of revenue on capex
Croissance
Revenue Growth (5Y)
38,90%
Revenue (1Y)110,45%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Qualité
Return on Equity
-57,80%
ROIC-10,62%
Net Margin-10,24%
Op. Margin-12,80%
Sécurité
Debt / Equity
2,86
Current Ratio2,74
Interest Coverage-5,85
Valorisation
P/E Ratio
-49,17
P/B Ratio21,52
EV/EBITDAN/A
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 110,45% | Revenue Growth (3Y) | 83,81% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38,90% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 490,73M | Net Income (TTM) | -50,26M |
| ROE | -57,80% | ROA | -8,30% |
| Gross Margin | 85,51% | Operating Margin | -12,80% |
| Net Margin | -10,24% | Free Cash Flow (TTM) | 37,78M |
| ROIC | -10,62% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 2,86 | Current Ratio | 2,74 |
| Interest Coverage | -5,85 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -49,17 | P/B Ratio | 21,52 |
| P/S Ratio | 5,04 | PEG Ratio | 0,79 |
| EV/EBITDA | N/A | Dividend Yield | 0,00% |
| Market Cap | 2,47B | Enterprise Value | 2,71B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 490,73M | 233,18M | 145,24M | 109,46M | 131,84M |
| Net Income | -50,26M | -321,55M | -111,40M | -278,48M | -180,09M |
| EPS (Diluted) | -0,56 | -4,08 | -1,50 | -4,37 | -3,01 |
| Gross Profit | 419,65M | 225,43M | 133,79M | 105,04M | 128,02M |
| Operating Income | -62,82M | -323,83M | -388,14M | -319,81M | -199,43M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 605,19M | 594,13M | 788,91M | 672,59M | 776,63M |
| Total Liabilities | 490,36M | 535,05M | 588,10M | 629,73M | 474,52M |
| Shareholders' Equity | 114,83M | 59,08M | 200,81M | 42,85M | 302,11M |
| Total Debt | 328,73M | 401,58M | 404,78M | 407,49M | 261,99M |
| Cash & Equivalents | 93,04M | 58,54M | 58,18M | 61,69M | 165,75M |
| Current Assets | 437,57M | 416,70M | 616,78M | 486,44M | 582,83M |
| Current Liabilities | 159,90M | 200,75M | 177,91M | 142,16M | 124,09M |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Full Throttle
#1 of 146
Activité Récente
Entré
Full Throttle
Mar 24, 2026